Search

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...

Eye research: where next?

Eye research in the UK is underfunded relative to other areas of medical research and general awareness of sight loss and its prevention remains poor, messages that were reinforced in presentations and discussions during a recent research summit meeting in...

I WILL. An extraordinary challenge for Glaucoma UK’s 50th anniversary

As we celebrate our 50th anniversary year, we are reaching out to our glaucoma community, inviting everyone to join us in the fight against glaucoma so we won’t need to exist as a charity in 50 years’ time. Since the...

Four pillars: Exploring eye exigencies

This series explores the four pillars of advanced clinical practice and here, Jem Ann Bautista explores the pillar of clinical practice. As day case theatre practitioners in one of London’s biggest and busiest centres, our team is trained to cater...

The history of ophthalmology: John Argyll Robertson and Douglas Moray Cooper Lamb Argyll Robertson

The author shares the story of an extraordinary father and son, two of the major figures in defining the specialty of ophthalmology as we know it today. The renowned Glasgow Surgeon Peter Lowe described ophthalmic surgery in his legendary surgical...